Medical Grand Rounds - "SGLT2 Inhibitors"
Presenter: Jagmeet Singh, MD, Chief, Nephrology, Guthrie Medical Group, P.C., Sayre, PA
At the conclusion of this activity, participants should be able to:
- Describe the burden and progression of chronic kidney disease in United States.
- Review SGLT2 inhibitors, mechanism of action and various trials.
- Discuss the updated guidelines about the use of SGLT2 inhibitors.
Date, Time and Location: Friday, May 19, 2023 at noon on Microsoft Teams®
Register: Email Trish.Stern@guthrie.org to be included.
This program is intended for: Physicians, Advanced Practice Providers, Fellows, Residents, Medical and Nursing Students, and other Ancillary Healthcare Caregivers.
Accreditation Statement: “The Guthrie Clinic is accredited by the Pennsylvania Medical Society to provide continuing medical education for physicians.”
Designation Statement: “The Guthrie Clinic designates this live activity for a maximum of (1.0) AMA PRA Category I Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.”
Disclosure Statement: “Faculty and all others who have the ability to control the content of continuing medical education activities provided by The Guthrie Clinic are expected to disclose to the audience whether they do or do not have any real or apparent relevant financial relationships related to this educational activity.” “The presenting faculty/planning committee for this educational activity have no relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.”